Product Information

DEXTROAMP-AMPHETAMIN 30 MG TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2841 per EA under NDC 68462065301. Its NADAC has been published 71 times since Jul 16, 2025.

FDA first approved this application on Jul 5, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEA Schedule CII

Strength

7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1

NDC

68462065301

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA210754

FDA Approved

7/5/2022

TE Code

AB

On Market Since

5/12/2025

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has been published 71 times since Jul 16, 2025, and over the history we have for it it has declined 15.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2841 per EA
All-time high$0.3373 (Jul 16, 2025)
All-time low$0.2841 (Nov 18, 2026)
52-week high$0.3153
52-week low$0.2841
Median price$0.3095
Average price$0.3091
Largest weekly change-4.7% (Sep 17, 2025)
Weeks tracked71
Tracking sinceJul 16, 2025

Price History

1W

-2.0%

1M

-2.0%

3M

-6.3%

6M

-7.1%

1Y

-8.5%

3Y

N/A

5Y

N/A

All

-15.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHETAMIN 30 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 30 MG TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2841 per EA (NDC 68462065301), effective Nov 18, 2026.

How has the price of DEXTROAMP-AMPHETAMIN 30 MG TAB changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has declined 15.8%. It has been tracked across 71 weekly CMS publications since Jul 16, 2025.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 30 MG TAB?

Since Jul 16, 2025, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has ranged from a low of $0.2841 (Nov 18, 2026) to a high of $0.3373 (Jul 16, 2025), with a median of $0.3095 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 30 MG TAB?

No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMP-AMPHETAMIN 30 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DEXTROAMP-AMPHETAMIN 30 MG TAB?

DEXTROAMP-AMPHETAMIN 30 MG TAB (NDC 68462065301) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.